Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

NRF, TGX, KSP, PWRM, NHPR - Stock News! from




Power3 Medical Products, Inc. (OTC:PWRM)

How BC-SeraPro Works

BC-SeraPro is a blood serum test designed to diagnose breast cancer in individuals. The test is based on proteomic technology in which a blood serum sample drawn from a patient will monitor the concentration of each protein biomarker residing in a panel of blood serum protein biomarkers to determine if a patient has breast cancer. The biomarkers in the panel have been selected for their ability to discriminate breast cancer patients from non-cancerous patients. Power3’s statistical model evaluates the quantitative information of the protein biomarkers and automatically assigns a probability score. The probability score indicates to the physician that the patient “has cancer” or is “cancer-free”. The score reflects how strongly the patient sample fits the biostatistical model and if the patient should be recommended for further follow-up by the clinician.

Blood serum collection is a routine procedure performed by a clinician. A small sample of blood is drawn from a vein. When a blood sample is collected and stored in a tube without anticoagulant, it forms a clot after 30-60 minutes. The liquid portion remaining is the blood serum. This serum sample is then frozen and transported to the Power3 Medical CLIA certified laboratory, utilizing pre-approved carriers/delivery service, where sample preparation and analysis begins.

Power3 Medical Products, Inc., a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. The company was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003. Power3 Medical Products, Inc . was founded in 1992 and is based in The Woodlands, Texas.

To learn more about PWRM visit:

*****  National Health Partners, Inc. (OTC:NHPR)

Based on a seemingly arbitrary matrix of things, it is a new perquisite or a fantasy having access to affordable medical in the United States. Government insurance applications are available for the elderly, the permanently disabled, people with failing kidneys, the particular impoverished and children from low-income individuals. But how poor should one be to be eligible varies from state to state and from year to year. Staff members at most large providers and many other people can take advantage of group insurance plans negotiated through their employers. However millions of people who operate in low-paying service, retail or perhaps contracting jobs need to seek individual plans, which may be unaffordable or perhaps unavailable because of their healthcare histories. Others obtain insurance with insurance deductibles so high or insurance policy coverage limits so very low that one bad accident or illness may possibly bankrupt them. The need for affordable healthcare alternatives has never been greater.

“I am thrilled to announce that we have finally achieved profitability,” stated David M. Daniels, President and Chief Executive Officer of NHPR. “Due to the fact that our limited medical provider unexpectedly decided to exit the marketplace, we were unable to add any new CARExpress Plus limited medical sales during the 3rd quarter. Yet, despite this temporary setback, we were still able to substantially increase our revenue and reach profitability which is a testament to the underlying strength we have with our core CARExpress health discount programs. Although we achieved positive results in revenues and earnings, we anticipate much better results going forward into 2011.”

National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.” CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. NHPR’s primary target customer group is the 47 million Americans who have no health insurance of any kind. NHPR’s secondary target customer group includes the millions of Americans who lack complete health insurance coverage. NHPR is headquartered in Horsham, Pennsylvania.

To learn more about NHPR visit:


NorthStar Realty Finance Corp. (NYSE:NRF) a finance REIT that primarily originates and invests in commercial real estate debt, real estate securities and net lease properties, announced that it will host a conference call to discuss fourth quarter and full year 2010 financial results for the year ended December 31, 2010 on Thursday, February 24, 2011 at 2:00 p.m. Eastern time. Hosting the call will be David T. Hamamoto, Chairman and Chief Executive Officer, and Andrew C. Richardson, Executive Vice President and Chief Financial Officer. A press release with fourth quarter and fiscal year 2010 financial results will be issued before the market open on February 24, 2011.

NorthStar Realty Finance Corp. operates as a real estate investment trust in the United States. It invests in real estate debt business, which acquires, originates, and structures debt investments secured primarily by income-producing real estate properties.


Theragenics Corp. (NYSE:TGX) a medical device company serving the surgical products and prostate cancer treatment markets, announced it is suspending shipments of TheraSeed® palladium-103 brachytherapy seeds to Core Oncology, Inc. Core has been unable to pay its trade receivables in accordance with the contractually specified terms for products and services provided. Theragenics also has provided Core with a notice of termination of its supply and reseller agreement, under which Theragenics is the exclusive palladium-103 seed supplier to Core for the treatment of prostate cancer in the U.S. and Canada. To ensure that scheduled patient procedures can proceed as planned, the notice provides a brief transition period during which additional orders from Core will be accepted and honored.

Theragenics Corporation operates as a medical device company serving the cancer treatment and surgical markets primarily in the United States and Europe. It operates through two segments, Surgical Products and Brachytherapy Seed.


K-SEA Transportation Partners LP (NYSE:KSP) announced operating results for its second fiscal quarter ended December 31, 2010. The Company reported operating income of $0.7 million, excluding a $1.6 million net gain on sale of assets, for the quarter ended December 31, 2010. In the second fiscal quarter ended December 31, 2009 operating income was $3.0 million, excluding a $1.7 million one-time loss. Earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the second quarter of fiscal 2011 was $13.2 million excluding the aforementioned net gain on the sale of assets, compared to $15.9 million, before the one-time item, for the second quarter ended December 31, 2009.

K-Sea Transportation Partners L.P. provides marine transportation, distribution, and logistics services for refined petroleum products in the United States. As of September 1, 2009, the company operated a fleet of 69 tank barges and 66 tugboats.



Signup for FREE Daily Stock Alerts From


Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.  Crown Equity Holdings Inc. (OTCPK:CRWE) anticipates receiving 3,000,000 shares of (144) restricted common stock from the company, as well as 3,000,000 shares of free trading shares from a third party for six months of advertisement services for National Health Partners Inc. (OTC:NHPR).  Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).